Many people mistakenly assume that because Ronit Mazzoni has been blind since birth, her career choice must have been related to her condition.
Researchers have found that oxytocin, commonly known as the "love hormone" may not be crucial for the social behaviors it's known for.
I don't relish being a party pooper, but I have some bad news: Any way you sip it, alcohol is a low-grade poison. (We all …
Research into the destructive influence tiny DNA circles have on cancer presents endless ideas for clearly describing groundbreaking science.
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
After starting his career as a veterinarian, scientist John Gorzynski turned to research, investigating great ape genetics and cardiology.
Stanford researchers are developing a faster way to match each ulcerative colitis patient with the treatment that will work best for them.
Stanford researchers recommend changes to a report that reviewed a national screening and quarantine program for travelers coming to the US.
Researchers are using a new artificial intelligence-based program to help identify genes that underly diseases.
Researchers are searching large, diverse genetic databases to better understand the roots of diabetes in diverse populations.
Researchers at Stanford Medicine have discovered a possible molecule connection between Down syndrome and Alzheimer's disease.
Cardiology researchers at Stanford Medicine are increasingly turning to CRISPR to understand -- and maybe one day -- treat heart disease.
Researchers find that the ribosome, a protein-making machine, may contribute to diseases of aging, such as Alzheimer's and Parkinson's.
From the genetics of COVID-19, to cancer, to tonsils, this story is a wrap up of Scope's most read stories of 2021.
Researchers design a test that predicts how quickly patients metabolize a standardized tuberculosis drug, aiming to increase efficacy.
Stanford Medicine researchers conducted an experiment to find new genes that, when knocked out, boost immune cells' cancer-killing ability.